Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency of expression and prognostic implications of emerging molecular targets in pulmonary squamous cell carcinoma.

Indian journal of pathology & microbiology - 1 Jan 2026

Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Kumar Hemant, Tripathi Suryakant, Prakash Ved

Abstract excerpt

BACKGROUND: NSCLC-Squamous cell carcinoma (SCC) is characterized by poor survival largely due no definitive markers for targeted therapy. KRAS (Kirsten rat sarcoma viral oncogene homolog) is a proto-oncogene associated with resistance standard chemotherapy regimens. Discoidin domain receptor 2 (DDR2), fibroblast growth factor receptor-1(FGFR-1) and mesenchymal epithelial transition (MET) are receptor tyrosine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins p21(ras)

Share to Receptor, Fibroblast Growth Factor, Type 1

Source

Identifiers

PMID: 41553124
DOI: 10.4103/ijpm.ijpm_8_25

Genes

KRAS
DDR2
FGFR1
MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency of expression and prognostic implications of emerging molecular targets in pulmonary squamous cell carcinoma.PMID 41553124Read ↗

Genetic insight and therapeutic targets in squamous-cell lung cancer.Semantic proximity Read ↗

Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing.Semantic proximity Read ↗

Emerging Biomarkers in Personalized Therapy of Lung Cancer.Semantic proximity Read ↗

Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.Semantic proximity Read ↗

Role of FGF Receptors as an Emerging Therapeutic Target in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma.Semantic proximity Read ↗

Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.Semantic proximity Read ↗

EGFR-Mutated Squamous Cell Lung Cancer and Its Association With OutcomesSemantic proximity Read ↗

Association of DEK Gene Alterations with Prognosis and Immunotherapy Treatment in Advanced Squamous Cell Carcinoma of the LungSemantic proximity Read ↗

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.Semantic proximity Read ↗

Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.Semantic proximity Read ↗

FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.